Related Experiment Video

Updated: May 20, 2026

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

Weak binder for MHC molecule is a potent Mycobacterium tuberculosis-specific CTL epitope in the context of HLA-A24

Yan Wang1, Meiyi Sun, Min He

  • 1Department of Microbiology, Nanjing Center for Disease Prevention and Control, Zizhulin 2, Nanjing 210003, China.

Microbial Pathogenesis
|July 24, 2012
PubMed

Insights

Researchers identified a novel peptide from Mycobacterium tuberculosis (Mtb) that stimulates cytotoxic T lymphocytes (CTLs) in HLA-A24 positive tuberculosis patients, offering potential for new Mtb vaccines and immunotherapies.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Tuberculosis (TB) remains a significant global health challenge.
  • Pathogen-specific cytotoxic T lymphocytes (CTLs) recognize antigenic peptides presented by Major Histocompatibility Complex (MHC) molecules, specifically Human Leukocyte Antigen (HLA) in humans.
  • HLA-A restricted responses are crucial for understanding cellular immunity and developing vaccines against Mycobacterium tuberculosis (Mtb).

Purpose of the Study:

  • To identify and characterize novel Mtb-derived antigenic peptides with binding motifs for the HLA-A24 molecule.
  • To assess the capacity of these peptides to stimulate peptide-specific CTLs in HLA-A24 positive individuals.

Main Methods:

  • Screening of peptides derived from Mtb culture filtrate protein (CFP10) and early secretory antigenic target (ESAT-6).
  • In vitro refolding assays to determine binding affinity to HLA-A24.
  • Enzyme-linked immunospot (ELISPOT) assay and tetramer staining to assess CTL stimulation from peripheral blood mononuclear cells (PBMCs) of TB patients and healthy controls.

Main Results:

  • One novel peptide (Mtb ESAT-6 positions 5-14) was identified with binding motifs for HLA-A24.
  • This peptide induced peptide-specific CTLs in PBMCs from HLA-A24 positive TB patients, but not in HLA-A24 negative patients or healthy controls.
  • The identified epitope demonstrated weak binding to HLA-A24 in mini MHC refolding assays.

Conclusions:

  • The novel ESAT-6 derived peptide is recognized by CTLs in HLA-A24 positive TB patients.
  • This peptide, presented by a common HLA class I molecule, holds potential for Mtb immunotherapy and vaccine development in a significant patient population.

More Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin11:17

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin

Published on: March 10, 2021

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...